10x Genomics gets injunction against Parse Biosciences' ATAC Products
Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent litigation ...
Nasdaq12d
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
selling or offering for sale its planned ATAC and ATAC-Multiome Single Cell products. As part of this consent agreement, Parse admitted that 10x's ATAC-seq patents are valid, enforceable and ...